Pfizer
Natasha Tavahen has extensive work experience in the field of clinical data management. Natasha is currently working at Pfizer as a Sr. Director, Sr. Group Lead Data Monitoring & Management. Before joining Pfizer, they held positions at Novartis, Jubilant Clinsys, TKL Research, and Schering-Plough Research Institute, where they gained experience in various roles such as Director, Program Lead, Associate Director, Clinical Data Management, Manager, Clinical Data Management, and Clinical Data Manager. Natasha Tavahen has been working in the field since 2003 and has gradually progressed in their career, gaining expertise and leadership responsibilities.
Natasha Tavahen completed their Bachelor of Science degree in Biology at the University of Scranton from 1999 to 2003. Natasha then pursued their Master of Business Administration (MBA) degree with a focus on Marketing and International Management at the D'Amore-McKim School of Business at Northeastern University from 2007 to 2010.
This person is not in any teams
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.